Discover how next‑generation KRAS inhibitors are overturning the “undruggable” myth in oncology. Learn why KRAS was so hard to target, how covalent KRAS G12C inhibitors like sotorasib and adagrasib work, and what this revolution means for personalized cancer treatment.
- admin@condrug.com
- Mon - Sat: 8.00 am - 7.00 pm
We develop solutions for your clinical data needs